Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.

Published: Thursday 12th December 2024
ADVANCED SEARCH
Log in
Top
BMC Pediatrics
Published in:

Open Access 01-12-2024 | Metabolic Dysfunction-Associated Steatotic Liver Disease | Research

Prediction of hepatic fibrosis using the aspartate transaminase-to-platelet ratio index in children and adolescents with metabolic dysfunction-associated steatotic liver disease

Authors: Hye Young Jin, Eu Seon Noh, Hwalrim Jeong, II Tae Hwang

Published in: BMC Pediatrics | Issue 1/2024

Login to get access

Abstract

Background

Aspartate transaminase-to-platelet ratio index (APRI) is an easy and useful predictor of hepatic fibrosis in patients with chronic hepatic disease, and it significantly correlates with the degree of hepatic fibrosis in adult patients with metabolic dysfunction-associated steatotic liver disease (MASLD). This study aimed to evaluate the use of APRI in assessing the severity of MASLD in children and adolescents.

Methods

Medical records of 115 patients (males: 78; females: 37) with MASLD were retrospectively reviewed. The correlations between the APRI and clinical parameters that indicate the severity of MASLD were analyzed. Their ages ranged between 7.3 and 18.8 years old. Patients with hepatitis B or C infections were excluded from the study. The APRI score was calculated, and transient elastography for liver stiffness measurement (LSM) was performed for all the patients.

Results

The mean APRI score was 0.46 ± 0.26, ranging between 0.16 and 1.57. The LSM values ranged between 2.94 and 7.72 kPa. Body mass index-standard deviation score, transaminase levels, and HbA1c levels were higher in a group with abnormal LSM when divided into two groups according to LSM. The APRI score was greater in the group with abnormal LSM (0.40 ± 0.17 vs. 0.64 ± 0.40, P < 0.001). The APRI score was associated with LSM (r = 0.354, P < 0.001). Area under the curve of APRI for predicting abnormal LSM was 0.650 (95% confidence interval, 0.517–0.784) with a cutoff value of 0.74.

Conclusions

APRI score showed weak correlation with LSM. Further study encompassing various severity of hepatic fibrosis is needed for identifying better and sensitive non-invasive indicators in pediatric MASLD.
Literature
1.
Clemente MG, Mandato C, Poeta M, Vajro P. Pediatric non-alcoholic fatty liver disease: recent solutions, unresolved issues, and future research directions. World J Gastroenterol. 2016;22(36):8078–93.CrossRefPubMedPubMedCentral
2.
Berardis S, Sokal E. Pediatric non-alcoholic fatty liver disease: an increasing public health issue. Eur J Pediatr. 2014;173(2):131–9.CrossRefPubMed
3.
Park HK, Lim JS. Change of obesity prevalence and lifestyle patterns before and during COVID-19 among Korean adolescents. Ann Pediatr Endocrinol Metab. 2022;27(3):183–91.CrossRefPubMedPubMedCentral
4.
Takaya J, Higashino H, Takaya R, Sakaguchi H, Tanoue J, Higashide T, Moriguchi H, Nakao M, Takai Y. Effect of the COVID-19 pandemic lockdown on the physique of school-age children in Japan. Ann Pediatr Endocrinol Metab. 2023;28(2):124–30.CrossRefPubMedPubMedCentral
5.
Day CP. Non-alcoholic fatty liver disease: a massive problem. Clin Med (Lond). 2011;11(2):176–8.PubMed
6.
Shannon A, Alkhouri N, Carter-Kent C, Monti L, Devito R, Lopez R, Feldstein AE, Nobili V. Ultrasonographic quantitative estimation of hepatic steatosis in children with NAFLD. J Pediatr Gastroenterol Nutr. 2011;53(2):190–5.CrossRefPubMedPubMedCentral
7.
Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F, Marzano A, Rizzetto M. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol. 2011;54(1):64–71.CrossRefPubMed
8.
Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the study of Liver diseases. Hepatology. 2018;67(1):328–57.CrossRefPubMed
9.
European Association for the Study of the L. European Association for the Study of D, European Association for the study of O: EASL-EASD-EASO Clinical Practice guidelines for the management of non-alcoholic fatty liver disease. Obes Facts. 2016;9(2):65–90.CrossRef
10.
Nobili V, Vizzutti F, Arena U, Abraldes JG, Marra F, Pietrobattista A, Fruhwirth R, Marcellini M, Pinzani M. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology. 2008;48(2):442–8.CrossRefPubMed
11.
Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518–26.CrossRefPubMed
12.
13.
Amernia B, Moosavy SH, Banookh F, Zoghi G. FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran. BMC Gastroenterol. 2021;21(1):453.CrossRefPubMedPubMedCentral
14.
Rigamonti AE, Bondesan A, Rondinelli E, Cella SG, Sartorio A. The role of aspartate transaminase to platelet ratio index (APRI) for the prediction of non-alcoholic fatty liver Disease (NAFLD) in severely obese children and adolescents. Metabolites 2022, 12(2).
15.
Schwimmer JB, Dunn W, Norman GJ, Pardee PE, Middleton MS, Kerkar N, Sirlin CB. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology. 2010;138(4):1357–64. 1364 e1351-1352.CrossRefPubMed
16.
Ballestri S, Lonardo A, Romagnoli D, Carulli L, Losi L, Day CP, Loria P. Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. Liver Int. 2012;32(8):1242–52.CrossRefPubMed
17.
Marginean CO, Melit LE, Ghiga DV, Sasaran MO. Reference values of normal liver stiffness in healthy children by two methods: 2D shear wave and transient elastography. Sci Rep. 2020;10(1):7213.CrossRefPubMedPubMedCentral
18.
Kim JH, Yun S, Hwang SS, Shim JO, Chae HW, Lee YJ, Lee JH, Kim SC, Lim D, Yang SW, et al. The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects. Korean J Pediatr. 2018;61(5):135–49.CrossRefPubMedPubMedCentral
19.
Roehlen N, Crouchet E, Baumert TF. Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells 2020, 9(4).
20.
Taylor RS, Taylor RJ, Bayliss S, Hagstrom H, Nasr P, Schattenberg JM, Ishigami M, Toyoda H, Wai-Sun Wong V, Peleg N, et al. Association between Fibrosis Stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and Meta-analysis. Gastroenterology. 2020;158(6):1611–e16251612.CrossRefPubMed
21.
Catanzaro R, Aleo A, Sciuto M, Zanoli L, Balakrishnan B, Marotta F. FIB-4 and APRI scores for predicting severe liver fibrosis in chronic hepatitis HCV patients: a monocentric retrospective study. Clin Exp Hepatol. 2021;7(1):111–6.CrossRefPubMedPubMedCentral
22.
Jin W, Lin Z, Xin Y, Jiang X, Dong Q, Xuan S. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis. BMC Gastroenterol. 2012;12:14.CrossRefPubMedPubMedCentral
23.
Drolz A, Wolter S, Wehmeyer MH, Piecha F, Horvatits T, Schulze Zur Wiesch J, Lohse AW, Mann O, Kluwe J. Performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease with and without morbid obesity. Int J Obes (Lond). 2021;45(10):2197–204.CrossRefPubMed
24.
Ismaiel A, Leucuta DC, Popa SL, Fagoonee S, Pellicano R, Abenavoli L, Dumitrascu DL. Noninvasive biomarkers in predicting nonalcoholic steatohepatitis and assessing liver fibrosis: systematic review and meta-analysis. Panminerva Med. 2021;63(4):508–18.CrossRefPubMed
25.
De Matteis C, Cariello M, Graziano G, Battaglia S, Suppressa P, Piazzolla G, Sabba C, Moschetta A. AST to platelet ratio index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects. Sci Rep. 2021;11(1):14834.CrossRefPubMedPubMedCentral
26.
Younes R, Caviglia GP, Govaere O, Rosso C, Armandi A, Sanavia T, Pennisi G, Liguori A, Francione P, Gallego-Duran R, et al. Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease. J Hepatol. 2021;75(4):786–94.CrossRefPubMed
27.
Diaz JJ, Gura KM, Roda J, Perez-Atayde AR, Duggan C, Jaksic T, Lo CW. Aspartate aminotransferase to platelet ratio index correlates with hepatic cirrhosis but not with fibrosis in pediatric patients with intestinal failure. J Pediatr Gastroenterol Nutr. 2013;57(3):367–71.CrossRefPubMedPubMedCentral
28.
Teufel-Schafer U, Flechtenmacher C, Fichtner A, Hoffmann GF, Schenk JP, Engelmann G. Transient elastography correlated to four different histological fibrosis scores in children with liver disease. Eur J Pediatr. 2021;180(7):2237–44.CrossRefPubMedPubMedCentral
29.
de Ledinghen V, Le Bail B, Rebouissoux L, Fournier C, Foucher J, Miette V, Castera L, Sandrin L, Merrouche W, Lavrand F, et al. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr. 2007;45(4):443–50.CrossRefPubMed
30.
Yang HR, Kim HR, Kim MJ, Ko JS, Seo JK. Noninvasive parameters and hepatic fibrosis scores in children with nonalcoholic fatty liver disease. World J Gastroenterol. 2012;18(13):1525–30.CrossRefPubMedPubMedCentral
31.
Mansoor S, Yerian L, Kohli R, Xanthakos S, Angulo P, Ling S, Lopez R, Christine CK, Feldstein AE, Alkhouri N. The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease. Dig Dis Sci. 2015;60(5):1440–7.CrossRefPubMed
32.
Alkhouri N, Mansoor S, Giammaria P, Liccardo D, Lopez R, Nobili V. The development of the pediatric NAFLD fibrosis score (PNFS) to predict the presence of advanced fibrosis in children with nonalcoholic fatty liver disease. PLoS ONE. 2014;9(8):e104558.CrossRefPubMedPubMedCentral
33.
Song K, Lee HW, Choi HS, Park G, Lee HS, Kim SJ, Lee M, Suh J, Kwon A, Kim HS et al. Comparison of the Modified TyG Indices and Other Parameters to Predict Non-Alcoholic Fatty Liver Disease in Youth. Biology (Basel) 2022, 11(5).
34.
Cho Y, Tokuhara D, Morikawa H, Kuwae Y, Hayashi E, Hirose M, Hamazaki T, Tanaka A, Kawamura T, Kawada N, et al. Transient elastography-based liver profiles in a hospital-based Pediatric Population in Japan. PLoS ONE. 2015;10(9):e0137239.CrossRefPubMedPubMedCentral
35.
Kwon YD, Ko KO, Lim JW, Cheon EJ, Song YH, Yoon JM. Usefulness of transient elastography for non-invasive diagnosis of liver fibrosis in Pediatric non-alcoholic steatohepatitis. J Korean Med Sci. 2019;34(23):e165.CrossRefPubMedPubMedCentral
36.
Hebelka H, de Lange C, Bostrom H, Ekvall N, Lagerstrand K. Shear Wave Elastography in the differentiation of Nonfibrotic Versus Fibrotic Liver Disease in children: a prospective study with histological correlation. JPGN Rep. 2022;3(1):e156.CrossRefPubMed
37.
Schwimmer JB, Pardee PE, Lavine JE, Blumkin AK, Cook S. Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation. 2008;118(3):277–83.CrossRefPubMedPubMedCentral
38.
Kim M, Kim J. Cardiometabolic risk factors and metabolic syndrome based on severity of obesity in Korean children and adolescents: data from the Korea National Health and Nutrition Examination Survey 2007–2018. Ann Pediatr Endocrinol Metab. 2022;27(4):289–99.CrossRefPubMedPubMedCentral
39.
Choe J, Kim J, Moon JS. Cutoff values of body mass index for severe obesity in Korean children and adolescents: the 99th percentile versus 120% of the 95th percentile. Ann Pediatr Endocrinol Metab. 2023;28(2):131–7.CrossRefPubMedPubMedCentral
40.
Nallagangula KS, Nagaraj SK, Venkataswamy L, Chandrappa M. Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression. Future Sci OA. 2018;4(1):FSO250.CrossRefPubMed
41.
Gawrieh S, Wilson LA, Cummings OW, Clark JM, Loomba R, Hameed B, Abdelmalek MF, Dasarathy S, Neuschwander-Tetri BA, Kowdley K, et al. Histologic findings of Advanced Fibrosis and cirrhosis in patients with nonalcoholic fatty liver Disease who have normal aminotransferase levels. Am J Gastroenterol. 2019;114(10):1626–35.CrossRefPubMedPubMedCentral
42.
Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, Bertelli C, Fatta E, Bignamini D, Marchesini G, et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology. 2008;48(3):792–8.CrossRefPubMed
Metadata
Title
Prediction of hepatic fibrosis using the aspartate transaminase-to-platelet ratio index in children and adolescents with metabolic dysfunction-associated steatotic liver disease
Authors
Hye Young Jin
Eu Seon Noh
Hwalrim Jeong
II Tae Hwang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2024
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-024-05263-3

Other articles of this Issue 1/2024

Correction: Serum sickness-like reaction to D-Supplement: A Case Report

  • Open Access
  • Correction

Sleep initiation patterns and sleep quality among toddlers in the southeast of China: initial study results

  • Open Access
  • COVID-19
  • Original Research

Maple syrup urine disease diagnosed in a resource-limited setting in an infant in Nepal: a case report

Point prevalence surveys of antibiotic prescribing in children at a tertiary hospital in a resource constraint, low-income sub-Saharan African country—the impact of an antimicrobial stewardship program

Association between pregnancy intention and completion of newborn and infant continuum of care in Sub-Saharan Africa: systematic review and meta-analysis

  • Open Access
  • Original Research

The correlation between lung ultrasound scores and outcomes of high-flow nasal cannula therapy in infants with severe pneumonia

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar
Image Credits